Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palmicort added to salbutamol for rainfall-associated bronchospasm
IRCT20200109046061N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of budesonide and salbutamol in bronchoconstriction (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Shortness of breath, Respiratory rate and 1 more. Started Oct 2020; status: completed.
02
Drugs
budesonidesalbutamol
03
Conditions
bronchoconstriction
Beyond the preview
Go deeper on IRCT20200109046061N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200109046061N1.